233 related articles for article (PubMed ID: 15297962)
1. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior.
Ronnett BM; Kajdacsy-Balla A; Gilks CB; Merino MJ; Silva E; Werness BA; Young RH
Hum Pathol; 2004 Aug; 35(8):949-60. PubMed ID: 15297962
[TBL] [Abstract][Full Text] [Related]
2. Ovarian intestinal-type mucinous borderline tumors: a nomenclature change is long overdue.
Kurman RJ; Ronnett BM
Int J Gynecol Pathol; 2010 Nov; 29(6):552-3; author reply 553-4. PubMed ID: 20881857
[No Abstract] [Full Text] [Related]
3. Mucinous tumors of the ovary: a review.
Hart WR
Int J Gynecol Pathol; 2005 Jan; 24(1):4-25. PubMed ID: 15626914
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas.
Riopel MA; Ronnett BM; Kurman RJ
Am J Surg Pathol; 1999 Jun; 23(6):617-35. PubMed ID: 10366144
[TBL] [Abstract][Full Text] [Related]
5. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives.
Bell DA; Longacre TA; Prat J; Kohn EC; Soslow RA; Ellenson LH; Malpica A; Stoler MH; Kurman RJ
Hum Pathol; 2004 Aug; 35(8):934-48. PubMed ID: 15297961
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
[TBL] [Abstract][Full Text] [Related]
7. [Mucinous tumors of the ovary. Anatomo-clinical aspects, histological classification, prognostic factors and histogenesis].
Bouzourene H; Genton CY
Arch Anat Cytol Pathol; 1997; 45(4):192-8. PubMed ID: 9406476
[TBL] [Abstract][Full Text] [Related]
8. Nuclear morphometry and AgNOR quantification: computerized image analysis on ovarian mucinous tumor imprints.
Versa-Ostojić D; Stanković T; Stemberger-Papić S; Vrdoljak-Mozetic D; Manestar M; Krasević M
Anal Quant Cytol Histol; 2008 Jun; 30(3):160-8. PubMed ID: 18630841
[TBL] [Abstract][Full Text] [Related]
9. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
McCluggage WG; Young RH
Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
[TBL] [Abstract][Full Text] [Related]
10. Current challenges and opportunities for research on borderline ovarian tumors.
Sherman ME; Berman J; Birrer MJ; Cho KR; Ellenson LH; Gorstein F; Seidman JD
Hum Pathol; 2004 Aug; 35(8):961-70. PubMed ID: 15297963
[TBL] [Abstract][Full Text] [Related]
11. [Mucinous ovarian neoplasms. Prognostically mostly excellent, infrequently a wolf in sheep's clothing].
Lax S; Staebler A
Pathologe; 2014 Jul; 35(4):327-35. PubMed ID: 24962632
[TBL] [Abstract][Full Text] [Related]
12. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas.
Rodríguez IM; Prat J
Am J Surg Pathol; 2002 Feb; 26(2):139-52. PubMed ID: 11812936
[TBL] [Abstract][Full Text] [Related]
13. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.
Hauptmann S; Friedrich K; Redline R; Avril S
Virchows Arch; 2017 Feb; 470(2):125-142. PubMed ID: 28025670
[TBL] [Abstract][Full Text] [Related]
14. Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow-up.
Hoerl HD; Hart WR
Am J Surg Pathol; 1998 Dec; 22(12):1449-62. PubMed ID: 9850171
[TBL] [Abstract][Full Text] [Related]
15. Current issues in the pathology of ovarian cancer.
Rabban JT; Bell DA
J Reprod Med; 2005 Jun; 50(6):467-74. PubMed ID: 16050571
[TBL] [Abstract][Full Text] [Related]
16. Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal.
Prat J
Adv Anat Pathol; 1999 Sep; 6(5):247-74. PubMed ID: 10472378
[TBL] [Abstract][Full Text] [Related]
17. Expression of c-myc and mutation of the KRAS gene in patients with ovarian mucinous tumors.
Li XS; Sun J; He XL
Genet Mol Res; 2015 Sep; 14(3):10752-9. PubMed ID: 26400304
[TBL] [Abstract][Full Text] [Related]
18. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential.
Ronnett BM; Kurman RJ; Zahn CM; Shmookler BM; Jablonski KA; Kass ME; Sugarbaker PH
Hum Pathol; 1995 May; 26(5):509-24. PubMed ID: 7750935
[TBL] [Abstract][Full Text] [Related]
19. Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification.
Amin MB; Smith SC; Eble JN; Rao P; Choi WW; Tamboli P; Young RH
Am J Surg Pathol; 2014 Aug; 38(8):1033-45. PubMed ID: 25025366
[TBL] [Abstract][Full Text] [Related]
20. Expression of hepatocyte nuclear factor 4 alpha in primary ovarian mucinous tumors.
Sugai M; Umezu H; Yamamoto T; Jiang S; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2008 Nov; 58(11):681-6. PubMed ID: 18844932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
